INTERNATIONAL BIOTECHNOLOGY TRUST PLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$564,705
-24.7%
23,5000.0%0.19%
-16.7%
Q2 2023$750,355
+4.5%
23,5000.0%0.23%
+14.0%
Q1 2023$717,925
-21.9%
23,5000.0%0.20%
-29.6%
Q4 2022$919,085
-17.9%
23,5000.0%0.28%
-20.9%
Q3 2022$1,119,000
-95.2%
23,500
+2482.4%
0.36%
+46.5%
Q2 2022$23,500,0009100.24%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders